The document discusses the establishment of a national Pharmacovigillance center in Pakistan to monitor adverse drug reactions and ensure drug safety. It outlines that the center would collect voluntary reports from healthcare professionals and the public on suspected adverse reactions, lack of drug efficacy, and pharmaceutical defects. The center would work to establish standardized Pharmacovigillance processes in Pakistan and expand monitoring to areas like antibiotics resistance, medical devices, and traditional medicines.